DT
MIRM icon

Diversified Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

Diversified Trust’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
19,050
+8,305
+77% +$834K 0.04% 248
2026
Q1 		$993K Buy
+10,745
New +$1.01M 0.02% 463

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Diversified Trust's MIRM Position: Q2 2026 in Review

Diversified Trust increased its Mirum Pharmaceuticals (MIRM) stake by 77% in Q2 2026, buying an estimated $834K and bringing the position to 19,050 shares worth $2.23M. The position accounts for 0.04% of the portfolio, ranked #248.

Diversified Trust first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Diversified Trust held 19,050 shares of Mirum Pharmaceuticals worth $2.23M as of Q2 2026.
  • Diversified Trust bought 8,305 Mirum Pharmaceuticals shares in Q2 2026, an estimated $834K.
  • Mirum Pharmaceuticals made up 0.04% of Diversified Trust's portfolio in Q2 2026, its #248 holding.
  • Diversified Trust first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.